BioStock: Article about CombiGene’s epilepsy project published in Gene Therapy
CombiGene recently achieved a milestone with the publication of a scientific article in Gene Therapy, a journal under the Nature Publishing Group. The paper presents the preclinical research findings of CombiGene’s epilepsy project CG01, which has been licensed to Spark Therapeutics.
Read the article about CombiGene at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/